Replies to post #91892 on Bioelectronics Corp (BIEL)

[DewmBoom]

Opinions vary. When the FDA clears Actipatch, the stock pps will rise by 35,000% in one day with millions of dollars in trading. It is going to be the birth of a new universe. That is why I call it the BIG BANG!

[hammy3777]

You fail to recognize there will be greater buying pressure that will more than offset the selling. There are many holding 100's of millions of shares that will be with held from the initial feeding frenzy. They are the smart ones realizing the company will be highly successful in the market place. The real money to be made is in the long term. Propensity? Which stock history have you been following?

[seven-up]

LOL right wow in the red with FDA clearance, WRONG speculation in the post related to Biel GEEEEEEEZ REALLY

[slopak]

When Fda OTC comes this company becomes golden on its OWN feat!

Because every American in need Will say goodbye to the oppoids and hello to a Side effect free / affordable And healing alternative like the cleared Actipatch!

The potential Will be mind boggling and the SP Will Go to the roof

when investors start to realize the mega potential iff Fda OTC cleared the SP Will fly one way or another

Nobody can change that fact not even you lol

[Zorax]

That's a strong scenario, however, when one looks at the 'patents' they are not stand alone invented designs themselves but only additions to earlier patents. I don't think the value is nearly as high on amended flyer patents. imo.

[Gailm]

That is an interesting thought, GetSeriousOK

Patent licensing generally runs 1-4%, and many times that assignment can be made outside the company without fear of "Corporate Opportunity" actions, preserving that income stream even in Bankruptcy.

Having looked at the whole picture, this SCAM equates to a "Moller" model of infinite research/investment/approval cycle without obtaining anything but enrichment for the founders.

The SEC has gotten aggressive with this model of late, with huge fines and other restrictions on fund raising and hypothecation of stock for cash.

I would say the FDA DENIAL will trigger that course of review, and then perhaps the scenario you laid out may occur.

In any event: Dead Company Walking.

As an aside, this is the trouble with penny sub pennies--it attracts an uneducated investor base, easily swayed by visions of greed and highly manipulated by the company. The SEC has issued many warning s about these SCAM companies of late--particular to the MJ new emergence field.

The OTC really needs to overhaul this whole segment of stocks.

Hopefully they are moving toward that.

Thank You for your post.